chrisvoncsefalvay/vaers-outcomes huggingface dataset:
blood comes out immediately after he get the shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (blood comes out immediately after he get the shot) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (blood comes out immediately after he get the shot). At the time of the report, VACCINATION SITE HAEMORRHAGE (blood comes out immediately after he get the shot) outcome was unknown.            No concomitant medication were reported.  No treatment medication were reported.
hives; memory loss; difficulty concentrating; brain fog; 2 small lesions on her brain; mast cell cognition problem; connective tissue disorder; dysautonomia; rashes; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives), AMNESIA (memory loss), DISTURBANCE IN ATTENTION (difficulty concentrating), FEELING ABNORMAL (brain fog) and CENTRAL NERVOUS SYSTEM LESION (2 small lesions on her brain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Idiopathic urticaria, Memory loss, Intelligence decreased, Concentration ability impaired, Connective tissue disorder and Dysautonomia.    On 09-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (hives), AMNESIA (memory loss), DISTURBANCE IN ATTENTION (difficulty concentrating), FEELING ABNORMAL (brain fog), CENTRAL NERVOUS SYSTEM LESION (2 small lesions on her brain), COGNITIVE DISORDER (mast cell cognition problem), CONNECTIVE TISSUE DISORDER (connective tissue disorder), AUTONOMIC NERVOUS SYSTEM IMBALANCE (dysautonomia) and RASH (rashes). At the time of the report, URTICARIA (hives), AMNESIA (memory loss), DISTURBANCE IN ATTENTION (difficulty concentrating), FEELING ABNORMAL (brain fog), CENTRAL NERVOUS SYSTEM LESION (2 small lesions on her brain), COGNITIVE DISORDER (mast cell cognition problem), CONNECTIVE TISSUE DISORDER (connective tissue disorder), AUTONOMIC NERVOUS SYSTEM IMBALANCE (dysautonomia) and RASH (rashes) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Eosinophil count: elevated (High) elevated. On an unknown date, Monocyte count: elevated (High) elevated. On an unknown date, Platelet count: low (Low) low. On an unknown date, Tryptase: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Past medical history of the patient was not reported. Current condition of the patient also included hereditary alpha tryptasemia.  Concomitant medication of the patient was not reported.  The patient also experienced gene triplication.  No treatment information was provided by the reporter.
On December 31st I started having chest pain around 05:15 PM. Pains got sharper and sharper. My husband took me to ER. Ran test and said no problems with the heart and tested positive of Covid. Before this event. I was having shortness of breath, like labored breathing. i went to Pumonologist and heart doctor. Neither said it was Covid until I went to ER on December 31st. Labored breathing increased and still occurring. I was hospitalized Tuesday and was told it was inflammation of rib cage. Breathing is a little better but not back to normal.
This is a spontaneous report from a contactable consumer (patient). A 76-year-old female patient received second dose of PREVNAR 13 (reported as PREVNAR 23, pending clarification), via an unspecified route of administration at left arm on 29Oct2018 13:45 at single dose for immunization. The patient had no other vaccines administered with suspect. Prior vaccinations within 4 weeks: None. Medical history included carotid artery surgery from Feb2018, strokes from 1997 (she had her first stroke in 1997, then had two more after her carotid artery surgery), arm was sore from 2017 to an unknown date (her arm was sore but nothing like this. She did not have a NDC, lot number or expiration date for the vaccine she got last year). The patient's concomitant medications were not reported. The patient previously took first dose of PREVNAR 13 (also reported as PREVNAR 23) for immunization in Dec2017 at pharmacy. The patient experienced sick and horribly sore, lost 4 pounds, on 29Oct2018. In evening of the 29Oct2018, she got extremely tired and her arm was real sore. During that night, she woke up and her whole left side was excruciatingly sore and she couldn't lay on that side or her back. She just couldn't sleep, she said that pain went from the shot area to her shoulder to her shoulder blade. Then down her side to under her left arm and into her back. On that Tuesday (30Oct2018), patient had chills and slept all day on her right side. She couldn't eat anything as she had no appetite and was nauseated. On that Tuesday night, she couldn't sleep again because the pain was so bad. Then yesterday (31Oct2018) she slept until about 10 am and woke up thinking she was feeling better. She felt better last night and could feel the pain going away on her left side. At time of report, she was fine but she said that she did lose 4 pounds since 29Oct2018.  The patient said that she was just about great at time of report, this was the first day she was well. There was no any event required a visit to emergency room or physician's office. The outcome of events sick and horribly sore was recovering, the outcome of the other events was unknown.
This is a spontaneous report from a contactable consumer (patient). A 79-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 12Mar2021 (Batch/Lot number was not reported) as single dose for Covid-19 immunization. The patient received the 1st dose of BNT162B2 on an unspecified date for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that he had both of the Pfizer Covid 19 vaccines and the last one was on 12Mar2021. The patient stated that on 02Apr2021 he had a bone biopsy and it came out good with one exception, they found a cluster of T-cells that pathology was unable to explain. The patient further stated that he has multiple myeloma. The patient added that they theorized it may have come from the vaccination and was not concerned about it nor did the HCP want to follow up with it. The patient added that in previous years the T-cells did not show up but this time they did. The outcome of event was unknown.  Information about lot/batch number has been requested.
2-3 inches below vaccine site, the area was red and edematous painful covering a very large area. After being assessed by a FNP, pt was given antibiotics. Site was back to normal by 10/24/16 except for slight edema. On the 21st before pt. took antibiotics, the site appeared as though there was SQ bleeding below the 2nd day reaction site. Like gravity as though there was bleeding internally.
The day after I received the vaccine I started feeling nauseous around 11:30 AM.  I went home from work and began vomiting at approximately 3 pm.  I felt feverish and had chills as well as  strong body aches.  For the next 3 days I still felt weak and tired, but have been fine since then.
Patients father called and said that the child developed a rash with red papules all over and he took the child to several different Doctors (6 times in all) with multiple different diagnosis  from Bug bites to poison Ivey to scabies he has had several topical ointments to apply. Stating he never applied for more that 2-3 days as they showed no improvement. Stated that the physician gave a steroid shot at one point with no help. Now the child has developed blisters 3 blister just broke out about a week ago  1 on leg 2 in head. They all sleep in the same bed. No other children have the rash or blister or bug bite.  Father thinks that this was a reaction to the polio vaccination. Although I informed him that this is not a symptom that I have ever known polio vaccine to cause the child could be having an allergic reaction to something. I suggested an allergy specialist or Dermatologist, and told him that I would enter his complaint as a VAERS however I really think unlikely due to this being the 5 time the child has received this vaccine.
stomach ache; pain in all body; can't get off the couch; Can't move her arm, looks like she was hit by a baseball bat; really bad headache; 103 F fever; nausea; This spontaneous case was reported by a nurse and describes the occurrence of ABDOMINAL PAIN UPPER (stomach ache), PAIN (pain in all body), BEDRIDDEN (can't get off the couch), INJECTED LIMB MOBILITY DECREASED (Can't move her arm, looks like she was hit by a baseball bat) and HEADACHE (really bad headache) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041LZ0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Type 2 diabetes mellitus (diabetes type 2 historical condition reported) and Blood pressure. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), MULTIVITAMINS + IRON and SEMAGLUTIDE (OZEMPIC) for an unknown indication.    On 13-Jan-2021 at 12:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach ache), PAIN (pain in all body), BEDRIDDEN (can't get off the couch), INJECTED LIMB MOBILITY DECREASED (Can't move her arm, looks like she was hit by a baseball bat), HEADACHE (really bad headache), PYREXIA (103 F fever) and NAUSEA (nausea). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, ABDOMINAL PAIN UPPER (stomach ache), PAIN (pain in all body), BEDRIDDEN (can't get off the couch), INJECTED LIMB MOBILITY DECREASED (Can't move her arm, looks like she was hit by a baseball bat), HEADACHE (really bad headache), PYREXIA (103 F fever) and NAUSEA (nausea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication also included diabetes type 2, blood pressure pills.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
On 10/27/2021, around 5pm I started having chills, muscle aches, headache and extreme fatigue. I also experienced nausea. I was supposed to start my period a few days later but it never came and I am not pregnant. My cycle is always regular and never late and I still have not started.
A few minutes after vaccination patient was in waiting room with her father explaining she was going to pass out. I stepped out to the waiting room and we got patient to sit down. Her body went limp, she started jerking and slid off of the chair onto the floor losing consciousness. All of this happened within a matter of a minute and then she became alert again. She began hyperventilating and I worked with her to calm her down while the other pharmacist got me a blood pressure cuff.
Multifocal Motor Neuropathy; This spontaneous report received from a health care professional, on behalf of her husband, and concerned a 50 year old male. The patient's height, and weight were not reported. The patient's past medical history included covid-19 infection in NOV-2020 which he fully recovered from within 3 weeks. The patient had no comorbidities, had never been in hospital, or had any health issues. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin unspecified) on an unspecified date for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, reported as within a week,  the patient became paralysed, "in unbearable pain, couldn't walk or even swallow correctly" and spent his 51st birthday in the Intensive Care Unit. On an unspecified date, Guillain-Barre syndrome was diagnosed but due to the rapid progression of the illness and the severity of the symptoms diagnosis was changed to mutifocal motor neuropathy. On an unspecified date, reported as 2 and a half months later, the patient was still undergoing treatment and therapy at home. He had been unable to work and his quality of life diminished.   The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of multifocal motor neuropathy was not reported. This report was serious (Hospitalization Caused / Prolonged, and Life Threatening).; Sender's Comments: V0: This spontaneous case concerns a 50-year-old male patient with a past medical history that included covid-19 infection in NOV-2020 who experienced multifocal motor neuropathy an unspecified time after receiving the Janssen Covid-19 vaccine. It was reported that within a week of vaccination the patient became paralyzed, and was in severe pain, couldn't walk, and had difficulty swallowing. He was admitted to the Intensive Care Unit. Guillain-Barre syndrome was diagnosed but due to the rapid progression of the illness and the severity of the symptoms the diagnosis was changed to mutifocal motor neuropathy. It was reported that 2 and a half months later, the patient was still undergoing treatment and therapy at home. Information regarding other potential etiologies was insufficient, and the occurrence of mutifocal motor neuropathy could represent background incidence of such events in the general population. Considering the temporal relationship, the event is assessed to have an indeterminate relationship with vaccination. Due to limited information and based solely on the reported temporal relationship, at this time the company causality is considered as related for reporting purposes.
SORE ARM; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch or lot numbers  No concomitant medications were reported. On an unspecified date, the subject experienced sore arm. The action taken with covid-19 vaccine  was not applicable. The outcome of sore arm was not reported. This report was non-serious. This case, from the same reporter is linked to 20210548212 and 20210548262.
Pt complained of nausea and acid reflux about 5 minutes after receiving the first dose of Pfizer covid vaccine. Nausea resolved after about 15 minutes and pt then complained of headache, sensitivity to light, lightheadedness and sore throat. Denied chest pain, SOB, difficulty breathing, swelling of face, tongue or throat, itchiness rash or hives. Pt maintained O2 98% or above while in clinic.
rash was red, hot to the touch, elevated, and blotchy; rash was red, hot to the touch, elevated, and blotchy; Red rash on the right side of her face; severe arm discomfort at the injection site; Fever; Malaise; This case was reported by a consumer via call center representative and described the occurrence of injection site discomfort in a adult female patient who received Herpes zoster (Shingrix) (batch number KX52G, expiry date unknown) for prophylaxis.   On 5th February 2020, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 5th February 2020, less than a day after receiving Shingrix, the patient experienced injection site discomfort. On 10th February 2020, the patient experienced skin warm, localized maculopapular rash and red rash. In February 2020, the patient experienced fever and malaise. On 15th February 2020, the outcome of the localized maculopapular rash and red rash were recovered/resolved. On an unknown date, the outcome of the injection site discomfort, fever, malaise and skin warm were recovered/resolved.   It was unknown if the reporter considered the injection site discomfort, fever, malaise, skin warm, localized maculopapular rash and red rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported, but it could be 64 or 65 years old. The patient received Shingrix vaccine in the right deltoid at approximately 12:00 noon. The patient experienced severe arm discomfort at the injection site within four hours of receiving the vaccine. She could not sleep on her right arm due to the discomfort. She experienced fever and general malaise that lasted for 48 hours. On Monday, 10th February 2020, she woke up with a red rash on the right side of her face. The rash was red, hot to the touch, elevated, and blotchy. She said it looked like hives. Tuesday and Wednesday the rash was on both sides of her face and was evident for 2-3 hours in the morning and then gone for the rest of the day. She went to her physician on Thursday, 13th February 2020, but the physician did not know what was causing the rash, she swabbed the area and would be going to run tests. On Saturday, 15th February 2020, she woke up and the rash was gone. No further information was provided.
onset of faint macular papular rash on face, trunk (chest, & back) & arms, 3 days p/vax;had onset of fever on day of vax which persisted off & on until day of rash;APAP was recommended for fever & discomfort;
Information has been received from a consumer regarding a case for ZOSTAVAX (MARRS #1409USA001454) concerning people (demographics unknown) who were vaccinated with ZOSTAVAX (dates of vaccination, lot numbers, dosages, and routes of administration not provided). The consumer reported that she has "now seen how many people have gotten Bell's palsy right after the shingle shot." The outcome of the Bell's palsy is unknown. Additional information has been requested.; Sender's Comments: US-009507513-1409USA001454:
Tingling Sensation on both hands between 3rd and 4th fingers. Soon after (15- 30 min) addition of tinging sensation center - base of both palms. After 1 hour tingling on back of each hand and base of each wrist. Patint took an aspirin and over the counter antihystamine. Tingling subsided within 1 hr of self medicating.
Pt received 3 immunizations, 10 minutes later reported feeling difficulty breathing.  Sat her down, took vitals (BP 137/110, HR 80), called 911, gave juice & crackers.  She reported feeling better when paramedics arrived.  No itching or swelling reported.  Final BP 129/94, RR 22, paramedics offered a ride to the hospital, pt declined.  They gave her no medical treatment, took vitals and declared her stable.  Screened pt for contraindications prior to vaccination, none reported by patient.  Administered TDAP (BOOSTRIX) in right arm IM, and PNEUMOVAX and H1N1 (Sanofi - .5ml) in left arm IM at 8:40 am.  Patient returned to vaccination station and stated "I can't breathe."  We seated her and began assess her airway, breathing and circulation and directed a staff member to call 911.  While one nurse talked to the 911 dispatcher the other nurse began taking vitals (BP: 137/110, HR:80).  We continued assessing and monitoring for changes and patient reported feeling better, with no airway tightness, itching, or swelling.  We gave her some juice and crackers, upon finding out that she had not eaten yet.  Paramedics arrived within minutes, took her vitals and asked if she would like a ride to the hospital.  Patient declined ride due to improved condition, paramedics agreed that no treatment was needed and declared her stable.  We continued to assess the patient after the paramedics were gone (BP 129/94, RR 22).  Patient was calm throughout, and reported no previous adverse reactions to vaccines.  Patient had received TDAP/BOOSTRIX and PNEUMONVAX before, and she felt it was the H1N1 vaccine that caused the reaction.  Since she did not have a personal phone number where she could be contacted, I gave her my cell phone number to call back in a day or two to follow up.  Also gave phone number to shelter staff.  Filled out Vaccine Adverse Event Reporting System form.
Bell's Palsy - left facial droop 3 days after administration. Went to primary dr. and got rx for Valtrex and Prednisone.
Approximately 2 -3  days after flu shot, patient started having pain - mainly lower torso, upper thighs, groin area - No longer has pain but now has progressed to vertigo like symptoms - weakness, equilibrium - can't walk, confusion, nausea, losing weight - Dr has done blood tests, 2 Ct's, chest x-ray, ekg and nothing abnormal - Information from medical records states pale, nausea,fatigue, dizziness.
Started to itch about 5 min after getting vaccine. Patient was premedicated with 25 mg of benadryl because she had a reaction to the first shot.  Patient had some red spots on her body.  Took another 25 mg of benadrly about 30 mins after the shot. Patient states that she cont to itch all over.
Rash on arms and legs. Super itchy at first and got milder after two days. Still persists after a week.
Tossing; Shaky; Flu-like; Threw up; Cramps; This is a spontaneous report received from a contactable consumer. The reporter is the patient.  A female patient received BNT162B2 (BNT162B2), administration date 17Apr2021 (Batch/Lot number: unknown) as dose number unknown, single for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RESTLESSNESS (non-serious) with onset 19Apr2021 02:00, outcome "recovering", described as "Tossing"; TREMOR (non-serious) with onset 19Apr2021 02:00, outcome "recovering", described as "Shaky"; INFLUENZA LIKE ILLNESS (non-serious) with onset 19Apr2021 02:00, outcome "recovering", described as "Flu-like"; VOMITING (non-serious) with onset 19Apr2021 02:00, outcome "recovering", described as "Threw up"; MUSCLE SPASMS (non-serious) with onset 19Apr2021 02:00, outcome "recovering", described as "Cramps".  Additional Information: The patient was calling about the Pfizer BioNTech COVID-19 vaccine. The patient had the vaccine on Saturday (17Apr2021) and she was feeling fine until last night around 2:00 AM (19Apr2021). The patient was tossing, got shaky, and flu-like. Then the patient had to go to the bathroom and then she threw up. Ever since then, the patient has stayed in bed and has cramps, right now she feels a little bit better. The patient wanted to make sure she is okay.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This case was reported by a pharmacist and described the occurrence of asthmatic reaction in a subject of unspecified age and gender who was vaccinated with FLUARIX (GlaxoSmithKline). On an unspecified date, the subject received dose of FLUARIX (details unknown). At an unspecified time after vaccination with FLUARIX, the subject experienced asthmatic reaction. At the time of reporting the outcome of the event was unspecified. The pharmacist considered the event was possibly related to vaccination with FLUARIX. The pharmacist reported two subjects had asthmatic reactions to FLUARIX vaccinations (see case ID A0999291A for details on the other subject). He did not have any further information.